Pfizer

Latest Stories

In this undated image provided by Progressive Corporation CEO Tricia Griffith poses for a photo. At $14.2 million, Griffith was the seventh highest-paid female CEO for 2018, as calculated by The Associated Press and Equilar, an executive data firm. (Progressive Corporation via AP) **FILE**

Progressive CEO defends racial and gender-based hiring at insurance giant

By Sean Salai - The Washington Times

In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid tablet samples in Freiburg, Germany in December 2021. As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. (Pfizer via AP, File)

Cases of COVID returning pose questions for Pfizer pill

By Matthew Perrone - Associated Press

FILE - A nursing student administers a Moderna COVID-19 vaccine at a vaccination center at UNLV, in Las Vegas on April 26, 2021. The Food and Drug Administration on Friday, April 29, 2022, set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children, typically the final step before authorizing the shots. (AP Photo/John Locher, File)

FDA sets June meetings on COVID vaccines for youngest kids

By Matthew Perrone - Associated Press

A health worker administers a dose of a Moderna COVID-19 vaccine during a vaccination clinic in Norristown, Pa., Tuesday, Dec. 7, 2021. Moderna on Thursday, April 28, 2022, asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.(AP Photo/Matt Rourke, File)

Moderna asks FDA to authorize COVID-19 vaccine for under 6

By Tom Howell Jr. - The Washington Times

A member of the Philadelphia Fire Department prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia, on March 26, 2021. A government advisory panel is meeting Thursday, Dec. 16, to determine if any restrictions are needed to the Johnson &amp; Johnson COVID-19 vaccine because of rare but serious blood clots. (AP Photo/Matt Rourke, File)

Johnson & Johnson suspends sales forecasts for its COVID-19 vaccine

By Tom Murphy - Associated Press

FILE - Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

Who really needs a second COVID booster? Here’s what to know

By Lauran Neergaard - Associated Press

Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

FDA authorizes a second COVID-19 booster for adults over 50

By Tom Howell Jr. - The Washington Times

This image provided by Pfizer shows the company's COVID-19 Paxlovid pills. Pfizer's and Merck's COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. (Pfizer via AP, File)

Pfizer to supply UNICEF with 4 million COVID-19 pills for poorer nations

By Tom Howell Jr. - The Washington Times

In this March 4, 2021 file photo, a vial of the Moderna COVID-19 vaccine rests on a table at a drive-up mass vaccination site in Puyallup, Wash., south of Seattle. Moderna’s COVID-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year. (AP Photo/Ted S. Warren, File)

Moderna seeks FDA authorization for 4th dose of COVID shot for all adults

By Zeke Miller - Associated Press

Prepared Pfizer COVID-19 vaccine syringes wait for patients at a middle school in Wheeling, Ill., Friday, June 11, 2021. As demand for COVID-19 vaccines collapses in many areas of the U.S., states are scrambling to use stockpiles of doses before they expire and have to be added to the millions that have already gone to waste. (AP Photo/Nam Y. Huh, File)

Pfizer seeking OK for 4th COVID dose for seniors

By Zeke Miller - Associated Press

A nurse holds a vial of the Pfizer COVID-19 vaccine for children ages 5 - 11, right, and a vial of the vaccine for adults, which have different colored labels, at a vaccination station in Jackson, Miss., Tuesday, Feb. 8, 2022. Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge that hit youngsters especially hard, according to new data from the Centers for Disease Control and Prevention released on Tuesday, March 1, 2022. (AP Photo/Rogelio V. Solis)

Pfizer to stop trials in Russia while maintaining access to medicines

By Tom Howell Jr. - The Washington Times

Prepared Pfizer COVID-19 vaccine syringes wait for patients at a middle school in Wheeling, Ill., Friday, June 11, 2021. As demand for COVID-19 vaccines collapses in many areas of the U.S., states are scrambling to use stockpiles of doses before they expire and have to be added to the millions that have already gone to waste. (AP Photo/Nam Y. Huh, File)

Pfizer CEO: Yearly booster shots likely needed to keep COVID-19 at bay

By Haris Alic - The Washington Times

A nurse holds a vial of the Pfizer COVID-19 vaccine for children ages 5 - 11, right, and a vial of the vaccine for adults, which have different colored labels, at a vaccination station in Jackson, Miss., Tuesday, Feb. 8, 2022. Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge that hit youngsters especially hard, according to new data from the Centers for Disease Control and Prevention released on Tuesday, March 1, 2022. (AP Photo/Rogelio V. Solis)

The U.S. should invest in better medical technology

By Jerry Rogers

World Health Organization Tedros Adhanom Ghebreyesus speaks during a media conference at an EU Africa summit in Brussels, Friday, Feb. 18, 2022. European Union leaders on Thursday lauded the bloc's vaccine cooperation with Africa in the fight against the coronavirus, but there was no sign they would move toward a temporary lifting of intellectual property rights protection for COVID-19 shots. (Johanna Geron, Pool Photo via AP)

WHO works to spread COVID vaccine technology to more nations

Associated Press

A person is injected with her second dose of the Pfizer COVID-19 vaccine at a Dallas County Health and Human Services vaccination site in Dallas, Thursday, Aug. 26, 2021. Federal health regulators on Friday, Feb. 11, 2022 delayed next week's public meeting to review Pfizers COVID-19 vaccine for children under 5, saying they want to see more data. (AP Photo/LM Otero, File)

FDA postpones review of child COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

Masks have been required in public, even for those who keep up with COVID-19 vaccinations. Effective prevention and treatment methods have eluded experts, who lose public trust with every policy reversal and failure to control the pandemic. (Associated Press)

COVID-19 vaccines’ flaws dash hopes of reaching herd immunity

By Tom Howell Jr. - The Washington Times

In this Thursday, July 15, 2021, file photo, Surgeon General Dr. Vivek Murthy speaks during the daily briefing at the White House in Washington. (AP Photo/Susan Walsh) ** FILE **

Surgeon general says FDA won’t cut corners in approving COVID-19 vaccine for young kids

By Tom Howell Jr. - The Washington Times

Nurse Lydia Holly prepares a child's COVID-19 vaccine dose, on Nov. 3, 2021, at Children's National Hospital in Washington. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children ages 5 and under while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February. (AP Photo/Carolyn Kaster, File)

Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5

By Tom Howell Jr. - The Washington Times

Nurse Lydia Holly prepares a child's COVID-19 vaccine dose, on Nov. 3, 2021, at Children's National Hospital in Washington. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children ages 5 and under while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February. (AP Photo/Carolyn Kaster, File)

Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5

By Tom Howell Jr. - The Washington Times

Nurse Lydia Holly prepares a child's COVID-19 vaccine dose, on Nov. 3, 2021, at Children's National Hospital in Washington. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children ages 5 and under while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February. (AP Photo/Carolyn Kaster, File)

U.S. urges Pfizer to seek COVID vaccine emergency authorization for kids under 5, AP source says

By Zeke Miller - Associated Press